Makoto Shintani

532 citations
9 papers · 435 indexed · h-index 8

Makoto Shintani

9 papers receiving 416 citations

Peers

Makoto Shintani
Comparison fields: 5 of 58
  • Virology 156
  • Pharmaceutical Science 82
  • Drug Discovery 2
  • Infectious Diseases 181
  • Organic Chemistry 132
Replace Jay Trivedi with:
Jay Trivedi United States
Jeffrey A. Ruell United States
Margarita C. Briñón Argentina
John D. Matiskella United States
Giuliana Cuzzucoli Crucitti Italy
Christer Sahlberg Sweden
Harvey I. Skulnick United States
Miao-Miao Horng United States
Karen R. Romines United States
Makoto Shintani relative to Jay Trivedi United States Jay Trivedi's profile →
Citations per field
00.5×
Jay Trivedi · 1×
Citations per year

Countries citing papers authored by Makoto Shintani

Since Specialization
Citations

This map shows the geographic impact of Makoto Shintani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Makoto Shintani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Makoto Shintani more than expected).

Fields of papers citing papers by Makoto Shintani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Makoto Shintani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Makoto Shintani. The network helps show where Makoto Shintani may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Makoto Shintani, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Makoto Shintani Line = papers co-authored together Makoto Shintani links everyone, so they are left out of the graph.

All Works

9 of 9 papers shown
#Work
1 20079
2 200323
3 200037
4 19997
5 199987
6 199960
7 199164
8 199090
9 198658

About Makoto Shintani

Makoto Shintani is a scholar working on Virology, Infectious Diseases, Hepatology, Pharmaceutical Science and Emergency Medicine, having authored 9 papers that have together received 435 indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (7 papers), HIV Research and Treatment (6 papers), Chemical Synthesis and Analysis (2 papers), Hepatitis C virus research (2 papers), Enzyme Catalysis and Immobilization (1 paper), Biochemical and Molecular Research (1 paper), Advancements in Transdermal Drug Delivery (1 paper) and Lipid Membrane Structure and Behavior (1 paper). The work is most often cited by research in Virology (156 citations), Pharmaceutical Science (82 citations), Drug Discovery (2 citations), Infectious Diseases (181 citations) and Organic Chemistry (132 citations). Makoto Shintani has collaborated with scholars based in Japan and United States. Frequent co-authors include Hideya Hayashi, Tsutomu Mimoto, Keizo Furuhashi, Takamasa Ueno, Yoshiaki Kiso, Ryohei Kato, Satoshi Nojima, Haruo Takaku, Naoko Hattori and Junya Imai. Their work appears in journals such as Chemical and Pharmaceutical Bulletin, Bioorganic & Medicinal Chemistry, Journal of Pharmaceutical Sciences, Antiviral Research and Proceedings of the National Academy of Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026